On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Funding for Harm Reduction under threat in Europe
Austerity, international donor retreat and poor political support are severely limiting harm reduction responses in several European Union (EU) countries.
Addiction medicine, 2nd ed. oxford specialist handbooks (OUP) - Discount offer
Edited by a global team of psychiatrists experienced in the treatment of addiction. 
How drug control policy and practice undermine access to controlled medicines
Prioritizing restrictive control is to the detriment of ensuring adequate availability of and access to controlled medicines, violating the rights of people who need them.
Reducing drug deaths: Heroin injection by appointment
The next step in addiction is assisting those who use heroin to inject.
How many people die from drugs?
The straight answer is that we do not know exactly how many drug-related deaths there are in the UK. This is because it depends on what definition of drug-related deaths is used, which is not a simple question.
Treating people for HCV infection in a barrier free low threshold setting
Written by Prof John Dillon, Professor of Hepatology & Gastroenterology School of Medicine, University of Dundee, Ninewells Hospital and Medical school.
Why we need harm reduction in the programme of AIDS 2018 Conference
The 22nd International AIDS Conference (AIDS2018) that will be held in Amsterdam 23 - 27 July 2018 will have special attention for Eastern Europe and Central Asia.
International drug policy – health before politics
The purpose of this paper is to explain how international drug policy continues to have a hugely damaging effect on population health, human rights and wellbeing, not only on individuals who consume and/or sell drugs but also on societies as a whole. And to review whether anything has changed after United Nations General Assembly Special Session.
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
The objective was to compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and cessation of treatment.
Preventing overdose deaths in Europe
More than 8 000 lives were reported to be lost to drug overdoses in Europe (EU28 plus Turkey and Norway) in the past year and this is an underestimate. Reducing drug-related deaths therefore remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events.
Share this on: